Absolute Antibody Licenses Novel Fc Silencing Technology From mAbsolveGemma Cann2024-11-28T14:56:42+00:00March 31st, 2022|News, Wilton Centre|
Platelet Services Appoints Senior Research Scientist To Support GrowthGemma Cann2024-11-28T14:56:55+00:00March 30th, 2022|BioCity Nottingham, News|
Cellomatics Strengthens Senior Management Team With Key AppointmentGemma Cann2024-11-28T15:13:09+00:00March 22nd, 2022|News|
Astellas And Pioneer Group Award Future Innovator Prize To ImmTune TherapiesGemma Cann2025-03-20T15:57:43+00:00March 17th, 2022|Accelerator, News|
From Kitchen Ingredient To Saving Lives – Phenotypeca Pioneers Improved Use Of Baker’s YeastGemma Cann2024-11-28T15:13:44+00:00March 10th, 2022|BioCity Nottingham, News|
Levelling Up White Paper And Life SciencesGemma Cann2024-11-28T14:08:19+00:00February 4th, 2022|Article|
New Partnerships With Leading FirmsGemma Cann2024-11-28T15:16:48+00:00January 25th, 2022|Accelerator, News|
Oxomics’ New Blood-Based Test The First To Identify If A Patient Has Cancer And If It Has SpreadGemma Cann2024-11-28T16:54:08+00:00January 11th, 2022|News|
The Epicentre Of The Drug Industry: How CROs Became The Backbone Of BiopharmaGemma Cann2024-11-28T14:09:23+00:00November 19th, 2021|Article|
